Skip to content

to evaluate the efficacy of two unani herbal medicine habb-e-asgand and habb-e-suranjan in the management of knee osteoarthritis

Comparing the efficacy of Habb-e-Asgand and Habb-e-Suranjan in Knee Osteoarthritis (Waja-ur-Rukbah): An Open Label Randomized Controlled Trial. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/083230
Enrollment
60
Registered
2025-03-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M170- Bilateral primary osteoarthritis of knee

Interventions

Intervention1: Habb-e-Suranjan: 2 pills (Habb) orally twice a day with water or milk after meal. Intervention2: Habb-e-Asgand: 2 pills (Habb) orally twice a day with water or milk after meal. Interven

Sponsors

Govt. Tibbi College And Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subject willing to participate in study and sign the informed consent form Subject between the age of 30 and 60 years of either gender BMI 30 to 39.9 Subject with clinical symptoms and signs Subject with primary OA Kellgren-Lawrence grading scale 1-3 Visual Analogue Scale (VAS)

Exclusion criteria

Exclusion criteria: Subject willing to participate in study and sign the informed consent form. Subject between the age of 30 and 60 years of either gender BMI 30 to 39.9 Subject with clinical symptoms and signs Subject with primary OA Kellgren-Lawrence grading scale 1-3 Visual Analogue Scale (VAS)

Design outcomes

Primary

MeasureTime frame
at baseline, 4th week, 8th week, 12th weekTimepoint: at baseline, 4th week,8th week, 12th week

Secondary

MeasureTime frame
Proposing safe & cost effective alternative for knee osteoarthritisTimepoint: at baseline 4 weeks 8 weeks & 12 weeks

Countries

India

Contacts

Public ContactDr MD NAJIBUR RAHMAN

Government Tibbi College and hospital

dr.razi.ahmed91@gmail.com7909035622

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026